INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
Pomerantz LLP is investigating potential securities fraud claims against The Chemours Company following the company's August 4, 2026 announcement of reduced full-year EBITDA guidance ($775M-$825M from $800M-$900M) and management's admission of channel oversupply issues. Chemours stock fell 18.63% on August 10, 2026, following the disclosure that approximately $65 million in aftermarket sales were misallocated.